× Medicines Discovery Catapult

Censo provides access to a diverse range of existing human iPSC lines, and ethically sources relevant human tissue, both healthy and with disease specific mutations, with which to custom generate new iPSC lines from large cohorts of individuals.

They can gene edit these lines to knock in, knock out or correct target genes of interest, and have developed reproducible differentiation protocols for a number of lineages, including microglia, astrocytes, cortical, and sensory neurons.

Using these cells for neurodegenerative and neuro-inflammatory disease discovery, they offer customisable phenotypic assays to deliver disease relevant compound characterisation, providing new insights and functional disease related understanding of their clients compounds.

Censo Bio are a member of our CRO Network, part of our Virtual R&D offering. You can find out more about them on their website.

Censo Bio logo